Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Orexigen obesity drug shows added benefits
Reuters, 10/26/09
Nearly half of patients who completed 56 weeks of treatment with Orexigen Therapeutics Inc's experimental obesity treatment, Contrave, lost at least 10 percent of their weight in a late–stage study and the drug also appeared to help cholesterol and blood sugar levels.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Imaging cuts in Medicare fee schedule: An access catastrophe and danger to patients
EurekAlert, 11/03/09
Even Low Alcohol Consumption Has A Negative Impact On Overall Health, Researchers Argue
ScienceDaily, 10/26/09
Be Overweight And Live Longer, German Study Suggests
ScienceDaily, 10/19/09
Sponsor
Article Search
Sponsor
Sponsor